WDR5 and neoplasm: In vitro and in vivo studies revealed that the SSSRRSS fragment is indispensable for the pro-tumor activity of PTENα, while the F133/F263 residues of WDR5, essential for the interaction with PTENα/β and other WIN site ligands, are necessary but not the only requirement for the pro-tumor activity of WDR5.